# THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

> **NCT03757650** · PHASE4 · COMPLETED · sponsor: **Fatih Sultan Mehmet Training and Research Hospital** · enrollment: 3 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Obesity, Morbid

## Interventions

- **DRUG:** Bismuth Subsalicylate

## Key facts

- **NCT ID:** NCT03757650
- **Lead sponsor:** Fatih Sultan Mehmet Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2020-11-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03757650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03757650, "THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03757650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*